Reven Pharmaceuticals, Inc.
Records under this name other than patents Reven Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 9 of 9 · Back to Reven Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,344,529 | Compositions and methods for the treatment of metabolic conditions Formerly held Lapsed on the fee record Ended May 31, 2026 · USPTO record | Lapsed on the fee record | Ended May 31, 2026 | USPTO record |
| US 9,867,849 | Methods of treating or ameliorating skin conditions with a magnetic dipole stabilized solution Lapsed on the fee record Ended Jan 16, 2026 · USPTO record | Lapsed on the fee record | Ended Jan 16, 2026 | USPTO record |
| US 11,202,798 | Method of treating or ameliorating skin conditions with a magnetic dipole stabilized solution Lapsed on the fee record Ended Dec 21, 2025 · USPTO record | Lapsed on the fee record | Ended Dec 21, 2025 | USPTO record |
| US 9,775,798 | Compositions and methods for the prevention and treatment of cardiovascular diseases Lapsed on the fee record Ended Oct 3, 2025 · USPTO record | Lapsed on the fee record | Ended Oct 3, 2025 | USPTO record |
| US 11,110,053 | Compositions and methods for the prevention and treatment of cardiovascular diseases Lapsed on the fee record Ended Sep 7, 2025 · USPTO record | Lapsed on the fee record | Ended Sep 7, 2025 | USPTO record |
| US 9,572,810 | Methods of treating or ameliorating skin conditions with a magnetic dipole stabilized solution Lapsed on the fee record Ended Feb 21, 2025 · USPTO record | Lapsed on the fee record | Ended Feb 21, 2025 | USPTO record |
| US 9,101,537 | Compositions and methods for the prevention and treatment of cardiovascular diseases Lapsed on the fee record Ended Aug 11, 2023 · USPTO record | Lapsed on the fee record | Ended Aug 11, 2023 | USPTO record |
| US 9,089,511 | Compositions and methods for the prevention and treatment of cardiovascular diseases Lapsed on the fee record Ended Jul 28, 2023 · USPTO record | Lapsed on the fee record | Ended Jul 28, 2023 | USPTO record |
| US 9,089,602 | Compositions and methods for the prevention and treatment of cardiovascular diseases Lapsed on the fee record Ended Jul 28, 2023 · USPTO record | Lapsed on the fee record | Ended Jul 28, 2023 | USPTO record |